Anavex Life Sciences Corp. (AVXL)
3.105
-0.14
(-4.17%)
USD |
NASDAQ |
Aug 24, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Total Assets (Quarterly) : 128.77M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 128.77M |
| December 31, 2025 | 132.99M |
| September 30, 2025 | 103.82M |
| June 30, 2025 | 102.43M |
| March 31, 2025 | 117.14M |
| December 31, 2024 | 124.04M |
| September 30, 2024 | 135.57M |
| June 30, 2024 | 141.62M |
| March 31, 2024 | 144.75M |
| December 31, 2023 | 148.07M |
| September 30, 2023 | 154.39M |
| June 30, 2023 | 157.81M |
| March 31, 2023 | 159.19M |
| December 31, 2022 | 148.37M |
| September 30, 2022 | 152.70M |
| June 30, 2022 | 160.22M |
| March 31, 2022 | 160.28M |
| December 31, 2021 | 156.90M |
| September 30, 2021 | 161.62M |
| June 30, 2021 | 166.42M |
| March 31, 2021 | 83.57M |
| December 31, 2020 | 54.33M |
| September 30, 2020 | 34.54M |
| June 30, 2020 | 31.63M |
| March 31, 2020 | 31.02M |
| Date | Value |
|---|---|
| December 31, 2019 | 31.42M |
| September 30, 2019 | 25.33M |
| June 30, 2019 | 21.97M |
| March 31, 2019 | 20.84M |
| December 31, 2018 | 22.10M |
| September 30, 2018 | 24.38M |
| June 30, 2018 | 26.79M |
| March 31, 2018 | 25.90M |
| December 31, 2017 | 28.34M |
| September 30, 2017 | 27.84M |
| June 30, 2017 | 24.91M |
| March 31, 2017 | 23.61M |
| December 31, 2016 | 21.37M |
| September 30, 2016 | 9.499M |
| June 30, 2016 | 9.844M |
| March 31, 2016 | 12.12M |
| December 31, 2015 | 14.02M |
| September 30, 2015 | 15.47M |
| June 30, 2015 | 7.979M |
| March 31, 2015 | 6.364M |
| December 31, 2014 | 7.050M |
| September 30, 2014 | 7.354M |
| June 30, 2014 | 9.314M |
| March 31, 2014 | 10.29M |
| December 31, 2013 | 0.1509M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 93.54M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.059M |
| Shareholders Equity (Quarterly) | 121.71M |
| Current Ratio | 18.24 |